Correlation Between Fortis Healthcare and Dhunseri Investments

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fortis Healthcare and Dhunseri Investments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fortis Healthcare and Dhunseri Investments into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fortis Healthcare Limited and Dhunseri Investments Limited, you can compare the effects of market volatilities on Fortis Healthcare and Dhunseri Investments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fortis Healthcare with a short position of Dhunseri Investments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fortis Healthcare and Dhunseri Investments.

Diversification Opportunities for Fortis Healthcare and Dhunseri Investments

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Fortis and Dhunseri is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Fortis Healthcare Limited and Dhunseri Investments Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dhunseri Investments and Fortis Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fortis Healthcare Limited are associated (or correlated) with Dhunseri Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dhunseri Investments has no effect on the direction of Fortis Healthcare i.e., Fortis Healthcare and Dhunseri Investments go up and down completely randomly.

Pair Corralation between Fortis Healthcare and Dhunseri Investments

Assuming the 90 days trading horizon Fortis Healthcare is expected to generate 1.36 times less return on investment than Dhunseri Investments. But when comparing it to its historical volatility, Fortis Healthcare Limited is 2.0 times less risky than Dhunseri Investments. It trades about 0.12 of its potential returns per unit of risk. Dhunseri Investments Limited is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  67,240  in Dhunseri Investments Limited on October 5, 2024 and sell it today you would earn a total of  132,990  from holding Dhunseri Investments Limited or generate 197.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fortis Healthcare Limited  vs.  Dhunseri Investments Limited

 Performance 
       Timeline  
Fortis Healthcare 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Fortis Healthcare Limited are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Fortis Healthcare sustained solid returns over the last few months and may actually be approaching a breakup point.
Dhunseri Investments 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dhunseri Investments Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable forward indicators, Dhunseri Investments is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Fortis Healthcare and Dhunseri Investments Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fortis Healthcare and Dhunseri Investments

The main advantage of trading using opposite Fortis Healthcare and Dhunseri Investments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fortis Healthcare position performs unexpectedly, Dhunseri Investments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dhunseri Investments will offset losses from the drop in Dhunseri Investments' long position.
The idea behind Fortis Healthcare Limited and Dhunseri Investments Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements